Puma Biotechnology Inc (PBYI) stock news · P/E 19, rev $228.4M
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
This PBYI news page leads with what Puma Biotechnology Inc filed — not a scraped headline mill.
No cached 8-K sentence for PBYI yet. We will not pad this page with generic market recap.
Latest reported PBYI revenue for 2025-12-31 was $228.4M. Net income was $31.1M. Revenue was down 0.9% from 2024-12-31 to 2025-12-31. PBYI currently screens at market cap $165.3M and trailing P/E 19.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PBYI stock page; for the tape open the quote page.
PBYI stock news FAQ
What are PBYI's latest revenue and net income?
Latest cached Puma Biotechnology Inc (PBYI) revenue for Dec 31, 2025 was $228.4M. Net income was $31.1M. Statements: https://lician.com/financials/pbyi
How did PBYI revenue change from the prior cached period?
Cached Puma Biotechnology Inc (PBYI) revenue was down 0.9% from $230.5M (Dec 31, 2024) to $228.4M (Dec 31, 2025). Statements: https://lician.com/financials/pbyi
What is PBYI's P/E ratio?
Puma Biotechnology Inc (PBYI) trailing P/E is 19.3 on the latest cached fundamentals snapshot.
What is PBYI's market cap?
Puma Biotechnology Inc (PBYI) market cap is $165.3M on the latest cached fundamentals snapshot.
What kind of company is PBYI?
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Where is PBYI stock news listed?
Cached stock news for Puma Biotechnology Inc (PBYI) is listed at https://lician.com/news/pbyi. Filings: https://lician.com/sec/pbyi
Not investment advice.